Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10426763 Pharmaceutical compositions comprising glitazones and NRF2 activators

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
November 21, 2016
0
Date of Patent
October 1, 2019
0
Patent Application Number
15356766
0
Patent Citations Received
‌
US Patent 12083107 Pharmaceutical compositions comprising glitazones and Nrf2 activators
0
‌
US Patent 11517552 Method for treating psoriasis
‌
US Patent 11633376 Method for treating metastatic prostate cancer
0
‌
US Patent 11648230 Method for treating rheumatoid arthritis
0
‌
US Patent 11654129 Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
0
‌
US Patent 11517553 Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
‌
US Patent 11633375 Method for treating infectious diseases with isothiocyanate functional compounds
0
Patent Inventor Names
Bjoern Colin Kahrs
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10426763
0
Patent Primary Examiner
‌
Sun Jae Yoo
0

Find more entities like US Patent 10426763 Pharmaceutical compositions comprising glitazones and NRF2 activators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo